anthralin has been researched along with Nail Diseases in 6 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Nail Diseases: Diseases of the nail plate and tissues surrounding it. The concept is limited to primates.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective randomized clinical trial was conducted on 50 patients with Alopecia areata who received DPCP alone (group D) or in combination with anthralin (group D/A)." | 9.41 | A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. ( Abedini, R; Aryanian, Z; Daneshmand, R; Ghandi, N; Hatami, P; Nasimi, M; Vance, TM, 2021) |
| "In a multicenter study 210 patients with moderate to severe chronic plaque-type psoriasis were randomly assigned to treatment with cyclosporine or etretinate." | 9.08 | Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. ( Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G, 1995) |
| "A prospective randomized clinical trial was conducted on 50 patients with Alopecia areata who received DPCP alone (group D) or in combination with anthralin (group D/A)." | 5.41 | A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. ( Abedini, R; Aryanian, Z; Daneshmand, R; Ghandi, N; Hatami, P; Nasimi, M; Vance, TM, 2021) |
| "In a multicenter study 210 patients with moderate to severe chronic plaque-type psoriasis were randomly assigned to treatment with cyclosporine or etretinate." | 5.08 | Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. ( Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G, 1995) |
| "Psoriasis is a chronic skin disease that affects millions of people throughout the world." | 2.44 | Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. ( Jiaravuthisan, MM; Muhn, CY; Murphy, F; Sasseville, D; Vender, RB, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ghandi, N | 1 |
| Daneshmand, R | 1 |
| Hatami, P | 1 |
| Abedini, R | 1 |
| Nasimi, M | 1 |
| Aryanian, Z | 1 |
| Vance, TM | 1 |
| Jiaravuthisan, MM | 1 |
| Sasseville, D | 1 |
| Vender, RB | 1 |
| Murphy, F | 1 |
| Muhn, CY | 1 |
| Anderson, TF | 1 |
| Levell, NJ | 1 |
| Shuster, S | 1 |
| Munro, CS | 1 |
| Friedmann, PS | 1 |
| Mahrle, G | 1 |
| Schulze, HJ | 1 |
| Färber, L | 1 |
| Weidinger, G | 1 |
| Steigleder, GK | 1 |
| Yamamoto, T | 1 |
| Katayama, I | 1 |
| Nishioka, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Subclinical Nail Involvement in Relevant Skin Diseases[NCT04092413] | 384 participants (Anticipated) | Observational | 2019-11-01 | Not yet recruiting | |||
| Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic: Nail Disease a Single-blind, Intrapatient Left-to-right Controlled Study.[NCT03263624] | Phase 4 | 30 participants (Anticipated) | Interventional | 2017-10-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for anthralin and Nail Diseases
| Article | Year |
|---|---|
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antimetabolites; Day Care, Medical; Di | 1982 |
4 trials available for anthralin and Nail Diseases
| Article | Year |
|---|---|
A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
Topics: Adolescent; Adult; Age of Onset; Alopecia Areata; Anthralin; Chronic Disease; Cyclopropanes; Drug Th | 2021 |
Remission of ordinary psoriasis following a short clearance course of cyclosporin.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Anthralin; Arthritis; Blood | 1995 |
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; | 1995 |
Topical anthralin therapy for refractory nail psoriasis.
Topics: Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Female; Humans; Male; Mid | 1998 |